Clinical Trial Update: Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing hematopoietic stem cell mobilization in idiopathic CD4+ lymphocytopenia patients and healthy controls to study T cell maturatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Cd4 Lymphocytopenia

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Idiopathic CD4-Positive, T-Lymphocytopenia | Phase 2 | Status: RECRUITING